Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
    Journal Article

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • Clinicopathologic features, molecular landscape, and prognostic implications of ovarian low-grade serous tumors with histologic transformation
    Journal Article

    Chui, M. H.; Kang, E. Y.; Kahn, R. M.; Chiang, S.; Zhou, Q.; Iasonos, A.; Manning-Geist, B.; Selenica, P.; Da Cruz Paula, A.; Long Roche, K.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • ctDNA analysis in ERBB2-amplified colorectal cancer: Biomarker analysis of the MyPathway trial
    Journal Article

    Meric-Bernstam, F.; Raghav, K. P. S.; Sweeney, C. J.; Swanton, C.; Spigel, D. R.; Bose, R.; Burris, H. A.; Friedman, C. F.; Espenschied, C. R.; Grindheim, J. M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Absolute risk of malignancy for biliary cytology based on World Health Organization (WHO) reporting system for pancreaticobiliary cytopathology
    Meeting Abstract

    Abraham, A. E.; Hargett, I.; Pharaa, Z.; Sears, C.; Murali, R.; Lin, O.; Sigel, C.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)
    Meeting Abstract

    Mahner, S.; Heitz, F.; Salehi, S.; Reuss, A.; Guyon, F.; Du Bois, A.; Harter, P.; Fotopoulou, C.; Querleu, D.; Mosgaard, B. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769)
    Meeting Abstract

    Traina, T. A.; Chen, Y.; Khoury, K.; Rugo, H. S.; Mayer, E. L.; Abdou, Y.; Melisko, M. E.; Pareja, F.; Weigelt, B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effect of post-discharge symptom monitoring on hospital readmissions: A randomized trial
    Meeting Abstract

    Daly, R. M.; Mao, J. J.; Cracchiolo, J. R.; Holland, J. C.; Huang, J.; Ebstein, A. M.; Walters, C.; Ackerman, J.; Raj, N. P.; Sanford, R. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Ultrasensitive ctDNA monitoring during CDK4/6 inhibitor therapy for metastatic breast cancer
    Meeting Abstract

    Ah-Reum An, J.; Jasper, J.; Cabel, L.; Yildirim, S. Y.; da Silva, E. M.; Patel, R. K.; LaBella, M.; Teysir, J.; Mai, N.; Safonov, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Randomized study evaluating optimal dose, efficacy and safety of E7386 + lenvatinib versus treatment of physicians’ choice in advanced/recurrent endometrial carcinoma previously treated with anti-PD-(L)1 immunotherapy
    Meeting Abstract

    Eskander, R. N.; Lee, J. Y.; Mirza, M.; Lorusso, D.; Mackay, H.; Ray-Coquard, I.; Oaknin, A.; Gonzalez-Martin, A.; Hase-gawa, K.; Corr, B.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • The impact of hyperthermia on cisplatin cytotoxicity in ovarian cancer cells
    Meeting Abstract

    Harlev, C.; Dopeso, H.; Green, H.; Stilling, M.; Bue, M.; Petersen, L. K.; Weigelt, B.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save